5,695
Views
20
CrossRef citations to date
0
Altmetric
Coronavirus – Research Paper

Socio-demographic, psychological, and experiential predictors of COVID-19 vaccine hesitancy in South Korea, October-December 2020

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1-8 | Received 15 Jun 2021, Accepted 15 Sep 2021, Published online: 06 Oct 2021

References

  • Eskola J, Duclos P, Schuster M, MacDonald NE. How to deal with vaccine hesitancy? Vaccine. 2015;33:4215–17. doi:10.1016/j.vaccine.2015.04.043.
  • Schuster M, Eskola J, Duclos P. Review of vaccine hesitancy: rationale, remit and methods. Vaccine. 2015;33:4157–60. doi:10.1016/j.vaccine.2015.04.035.
  • MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161–64. doi:10.1016/j.vaccine.2015.04.036.
  • Larson HJ, Wilson R, Hanley S, Parys A, Paterson P. Tracking the global spread of vaccine sentiments: the global response to Japan’s suspension of its HPV vaccine recommendation. Hum Vaccin Immunother. 2014;10:2543–50. doi:10.4161/21645515.2014.969618.
  • Michael CA, Team NORS, Ogbuanu IU, Team NORS, Storms AD, Team NORS, Achari P, Biya O, Nguku P, Mahoney F, et al. An assessment of the reasons for oral poliovirus vaccine refusals in northern Nigeria. J Infect Dis. 2014;210:S125–S30. doi:10.1093/infdis/jiu436.
  • Murakami H, Kobayashi M, Hachiya M, Khan ZS, Hassan SQ, Sakurada S. Refusal of oral polio vaccine in northwestern Pakistan: a qualitative and quantitative study. Vaccine. 2014;32:1382–87. doi:10.1016/j.vaccine.2014.01.018.
  • The SAGE Vaccine Hesitancy Working Group. Report of the SAGE working group on vaccine hesitancy. 2014.
  • Betsch C, Böhm R, Chapman GB. Using behavioral insights to increase vaccination policy effectiveness. Policy Insights Behav Brain Sci. 2015;2:61–73. doi:10.1177/2372732215600716.
  • Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, Böhm R. Beyond confidence: development of a measure assessing the 5C psychological antecedents of vaccination. PloS One. 2018;13:e0208601. doi:10.1371/journal.pone.0208601.
  • Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines. 2020;8:482. doi:10.3390/vaccines8030482.
  • Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: implications for public health communications. Lancet Regional Health Eur. 2021;1:100012. doi:10.1016/j.lanepe.2020.100012.
  • Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res. 2020;288:112954. doi:10.1016/j.psychres.2020.112954.
  • Chou W-YS, Budenz A. Considering Emotion in COVID-19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence. Health Commun. 2020;35:1718–22. doi:10.1080/10410236.2020.1838096.
  • Bendau A, Plag J, Petzold MB, Ströhle A. COVID-19 vaccine hesitancy and related fears and anxiety. Int Immunopharmacol. 2021;97:107724. doi:10.1016/j.intimp.2021.107724.
  • Fridman A, Gershon R, Gneezy A. COVID-19 and vaccine hesitancy: a longitudinal study. PloS One. 2021;16:e0250123. doi:10.1371/journal.pone.0250123.
  • Soares P, Rocha JV, Moniz M, Gama A, Laires PA, Pedro AR, Dias S, Leite A, Nunes C. Factors associated with COVID-19 vaccine hesitancy. Vaccines. 2021;9:300. doi:10.3390/vaccines9030300.
  • Fontanet A, Cauchemez S. COVID-19 herd immunity: where are we? Nat Rev Immunol. 2020;20:583–84. doi:10.1038/s41577-020-00451-5.
  • Salmon D, Opel DJ, Dudley MZ, Brewer J, Breiman R. Reflections on governance, communication, and equity: challenges and opportunities in COVID-19 vaccination: article examines the engagement and communication steps necessary to strengthen the COVID-19 vaccine roll out by federal, state, and local governments. Health Aff. 2021;40:419–25.
  • Velavan TP, Pollard AJ, Kremsner PG. Herd immunity and vaccination of children for COVID-19. Int J Infect Dis. 2020;98:14. doi:10.1016/j.ijid.2020.06.065.
  • Statistics of Korea. Population and housing census 2020; 2019.
  • StataCorp L. Stata survey data reference manual. Citeseer; 1985.
  • Rhodes A, Hoq M, Measey M-A, Danchin M. Intention to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021;21(5):e110. doi:10.1016/S1473-3099(20)30724-6.
  • Dodd RH, Cvejic E, Bonner C, Pickles K, McCaffery KJ, Ayre J, Batcup C, Copp T, Cornell S, Dakin T, et al. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021;21:318–19. doi:10.1016/S1473-3099(20)30559-4.
  • Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, Rubin GJ, Sevdalis N. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2021;17:1612–21.
  • Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020;14:e0008961. doi:10.1371/journal.pntd.0008961.
  • Karlsson LC, Soveri A, Lewandowsky S, Karlsson L, Karlsson H, Nolvi S, Karukivi M, Lindfelt M, Antfolk J. Fearing the disease or the vaccine: the case of COVID-19. Pers Individ Dif. 2021;172:110590. doi:10.1016/j.paid.2020.110590.
  • Taylor S, Landry CA, Paluszek MM, Groenewoud R, Rachor GS, Asmundson GJ. A proactive approach for managing COVID-19: the importance of understanding the motivational roots of vaccination hesitancy for SARS-CoV2. Front Psychol. 2020;11:2890. doi:10.3389/fpsyg.2020.575950.
  • Askelson NM, Campo S, Lowe JB, Smith S, Dennis LK, Andsager J. Using the theory of planned behavior to predict mothers’ intentions to vaccinate their daughters against HPV. J School Nurs. 2010;26:194–202. doi:10.1177/1059840510366022.
  • Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. N Engl J Med. 2020;382:1969–73. doi:10.1056/NEJMp2005630.
  • Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24. doi:10.1080/08870449908407311.
  • Egede LE, Ellis C. Development and testing of the multidimensional trust in health care systems scale. J Gen Intern Med. 2008;23:808–15. doi:10.1007/s11606-008-0613-1.
  • Bruder M, Haffke P, Neave N, Nouripanah N, Imhoff R. Measuring individual differences in generic beliefs in conspiracy theories across cultures: conspiracy Mentality Questionnaire. Front Psychol. 2013;4:225. doi:10.3389/fpsyg.2013.00225.
  • Schwarzer R, Fuchs R. Self-efficacy and health behaviours. Predict Health Behav. 1996;163:163–96.
  • Lapsley DK, Hill PL. Subjective invulnerability, optimism bias and adjustment in emerging adulthood. J Youth Adolesc. 2010;39:847–57. doi:10.1007/s10964-009-9409-9.
  • Lee C, Whetten K, Omer S, Pan W, Salmon D. Hurdles to herd immunity: distrust of government and vaccine refusal in the US, 2002–2003. Vaccine. 2016;34:3972–78. doi:10.1016/j.vaccine.2016.06.048.
  • Kim ES, Chin BS, Kang CK, Kim NJ, Kang YM, Choi J-P, Oh DH, Kim JH, Koh B, Kim SE, et al. Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: a preliminary report of the first 28 patients from the Korean cohort study on COVID-19. J Korean Med Sci. 2020;35(13):e142. doi: 10.3346/jkms.2020.35.e142.
  • Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, Schuster M, MacDonald NE, Wilson R. Measuring vaccine hesitancy: the development of a survey tool. Vaccine. 2015;33:4165–75. doi:10.1016/j.vaccine.2015.04.037.
  • Peretti-Watel P, Seror V, Cortaredona S, Launay O, Raude J, Verger P, Fressard L, Beck F, Legleye S, L’Haridon O, et al. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis. 2020;20(7):769–70. doi:10.1016/S1473-3099(20)30426-6.
  • Wolf ME, Luz B, Niehaus L, Bhogal P, Bäzner H, Henkes H. Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure. J Clin Med. 2021;10:1599. doi:10.3390/jcm10081599.